Study Shows ctDNA Test Detects Immunotherapy Response Early
A new study found the assay detected immunotherapy response in advanced cancer patients a median of 23 days after treatment—over five months earlier than imaging.
Read More
Search Results for: lung cancer
Labcorp Plans 500,000-Square-Foot Facility in Indiana to Expand Central Lab Services
Labcorp will build a 500,000-square-foot facility in Brownsburg, Indiana, expanding its Indianapolis-area lab capacity by 40% to support clinical trial operations.
Read More
Valley Diagnostics Licenses Biomarker Technology for Cancer, Disease Detection
Valley Diagnostics has secured exclusive global rights to develop point-of-care lateral flow tests for prostate cancer, lung cancer, and animal diseases, with product rollout planned for 2026.
Read More
Blood Test Identifies Lung Cancer Patients Who Will Respond to Immunotherapy
Researchers at Mass General Brigham have developed a blood test that predicts tarlatamab response in small cell lung cancer, showing 85% sensitivity and 100% specificity.
Read More
Tempus Launches AI-Powered Digital Pathology Suite for Biomarker Prediction
Tempus has introduced Paige Predict, an AI-powered pathology suite that analyzes H&E slides to predict 123 biomarkers across 16 cancer types when tissue samples are insufficient.
Read More